Fig. 2 (abstract P338).From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)Enoblituzumab Treated Prostatectomy CD8+ T Cell InfiltratesBack to article page